Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
J Heart Lung Transplant. 2017 Sep;36(9):985-995. doi: 10.1016/j.healun.2017.05.012. Epub 2017 May 12.
Extended criteria donor lungs deemed unsuitable for immediate transplantation can be reconditioned using ex vivo lung perfusion (EVLP). Objective identification of which donor lungs can be successfully reconditioned and will function well post-operatively has not been established. This study assessed the predictive value of markers of inflammation and tissue injury in donor lungs undergoing EVLP as part of the DEVELOP-UK study.
Longitudinal samples of perfusate, bronchoalveolar lavage, and tissue from 42 human donor lungs undergoing clinical EVLP assessments were analyzed for markers of inflammation and tissue injury. Levels were compared according to EVLP success and post-transplant outcomes. Neutrophil adhesion to human pulmonary microvascular endothelial cells (HPMECs) conditioned with perfusates from EVLP assessments was investigated on a microfluidic platform.
The most effective markers to differentiate between in-hospital survival and non-survival post-transplant were perfusate interleukin (IL)-1β (area under the curve = 1.00, p = 0.002) and tumor necrosis factor-α (area under the curve = 0.95, p = 0.006) after 30 minutes of EVLP. IL-1β levels in perfusate correlated with upregulation of intracellular adhesion molecule-1 in donor lung vasculature (R = 0.68, p < 0.001) and to a lesser degree upregulation of intracellular adhesion molecule-1 (R = 0.30, p = 0.001) and E-selectin (R = 0.29, p = 0.001) in conditioned HPMECs and neutrophil adhesion to conditioned HPMECs (R = 0.33, p < 0.001). Neutralization of IL-1β in perfusate effectively inhibited neutrophil adhesion to conditioned HPMECs (91% reduction, p = 0.002).
Donor lungs develop a detectable and discriminatory pro-inflammatory signature in perfusate during EVLP. Blocking the IL-1β pathway during EVLP may reduce endothelial activation and subsequent neutrophil adhesion on reperfusion; this requires further investigation in vivo.
被认为不适合立即移植的扩展标准供体肺可以通过体外肺灌注(EVLP)进行再处理。尚未确定可以成功再处理并在术后功能良好的供体肺的目标识别。本研究评估了作为 DEVELOP-UK 研究的一部分,在接受 EVLP 的供体肺中炎症和组织损伤标志物的预测价值。
对 42 例接受临床 EVLP 评估的人供体肺的灌流液、支气管肺泡灌洗液和组织的纵向样本进行分析,以评估炎症和组织损伤标志物。根据 EVLP 成功和移植后结果对水平进行比较。在微流控平台上研究了 EVLP 评估中用灌流液条件化的人肺微血管内皮细胞(HPMEC)上的中性粒细胞粘附。
区分住院期间存活和移植后非存活的最有效标志物是 EVLP 30 分钟后灌流液中的白细胞介素(IL)-1β(曲线下面积= 1.00,p = 0.002)和肿瘤坏死因子-α(曲线下面积= 0.95,p = 0.006)。灌流液中的 IL-1β 水平与供体肺血管内皮细胞中细胞间粘附分子-1的上调相关(R = 0.68,p < 0.001),并且在一定程度上与细胞间粘附分子-1(R = 0.30,p = 0.001)和 E-选择素(R = 0.29,p = 0.001)的上调相关,以及对条件化的 HPMEC 的中性粒细胞粘附(R = 0.33,p < 0.001)。灌流液中 IL-1β 的中和有效抑制了中性粒细胞对条件化的 HPMEC 的粘附(减少 91%,p = 0.002)。
供体肺在 EVLP 期间在灌流液中产生可检测和可区分的促炎特征。在 EVLP 期间阻断 IL-1β 途径可能会减少再灌注时内皮细胞的激活和随后的中性粒细胞粘附;这需要进一步的体内研究。